Incidence, risk factors and hospital burden in children under five years of age hospitalised with respiratory syncytial virus infections

Acta Paediatrica, International Journal of Paediatrics

Volumn 104, Issue 9, 2015, Pages 922-926

  Svensson, Charlotta ^a   Berg, Karin ^b   Sigurs, Nele ^c   Trollfors, Birger ^d  

^a Angered Hospital   (Sweden)

^b Northern Alvsborg Hospital   (Sweden)

^c Boras Lasarett   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hospitalisation; Incidence; Medication; Outcome; Respiratory syncytial virus

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; ANTIVIRUS AGENT; PALIVIZUMAB;

AGE DISTRIBUTION; ARTICLE; ASSISTED VENTILATION; CHILD; DATA BASE; FEMALE; HOSPITAL BED; HUMAN; INCIDENCE; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; AGE; HOSPITALIZATION; INFANT, PREMATURE, DISEASES; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SWEDEN;

AGE FACTORS; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 84939255682     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.13061     Document Type: Article

References (21)

1. Hall CB,. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-28.
2. Glezen WP, Taber LH, Frank AL, Kasel JA,. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-6.
3. Collins PL, Melero JA,. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 2011; 162: 80-99.
4. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE,. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352: 749-59.
5. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björkstén B,. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95: 500-5.
6. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, et al., Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65: 1045-52.
7. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al., The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-98.
8. Light M, Bauman J, Mavunda K, Malinoski F, Eggleston M,. Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida. Pediatr Infect Dis J 2008; 27: 512-8.
9. Fjaerli HO, Farstad T, Bratlid D,. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr 2004; 4: 25.
10. Murray J, Bottle A, Sharland M, Modi N, Aylin P, Majeed A, et al., Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One 2014; 9: e89186.
11. Eriksson M, Bennet R, Rotzén-Östlund M, von Sydow M, Wirgart B,. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 2002; 91: 593-8.
12. Brittain-Long R, Nord S, Olofsson S, Westin J, Anderson LM, Lindh M. Multiplex real-time PCR for detection of respiratory tract infections. J Clin Virol 2008; 41: 53-6.
13. Paramore LC, Ciuryla V, Ciesla G,. Liu L Economic impact of respiratory syncytial virus-related illness in the US. An analysis of national databases. Pharmacoeconomics 2004; 22: 275-84.
14. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR,. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr 2000; 137: 865-7.
15. Rossi GA, Medici MC, Merolla R, the "Osservatorio VRS" Study Group. Incidence of respiratory syncytial virus positivity in young Italian children referred to the emergency departments for lower respiratory tract infection over two consecutive epidemic seasons. Infection 2005; 33: 18-24.
16. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al., Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2011; 15: CD003123.
17. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al., Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2013; 4: CD004878.
18. Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al., Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134: e1474-502.
19. Plint AC, Grenon R, Klassen TP, Johnson DW,. Bronchodilator and steroid use for the management of bronchiolitis in Canadian pediatric emergency departments. CJEM 2015; 17: 46-53.
20. Mecklin M, Hesselmar B, Qvist E, Wennergren G, Korppi M,. Diagnosis and treatment of bronchiolitis in Finnish and Swedish children's hospitals. Acta Paediatr 2014; 103: 946-50.
21. Byington CL, Wilkes J, Korgenski K, Sheng X,. Respiratory syncytial virus-associated mortality in hospitalized infants and young children. Pediatrics 2015; 135: e24-31.